Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
International Journal of Radiation Biology|October 19, 2020
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter studyViviana Frantellizzi, Fabio Monari, Manlio Mascia, et al.Tumori|May 2, 2018
223Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experienceGiuseppe Boni, Sara Mazzarri, Claudia Cianci, et al.Minerva Urology and Nephrology|August 5, 2020
Radium-223 in mCPRC patients: a large real-life Italian multicenter studyViviana Frantellizzi, Fabio Monari, Manlio Mascia, et al.Frontiers in Oncology|December 29, 2022
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinomaMargherita Nannini, Andrea Repaci, Gianluca Ricco, et al.Annals of Nuclear Medicine|July 13, 2020
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter studyViviana Frantellizzi, Fabio Monari, Manlio Mascia, et al.Aging Clinical and Experimental Research|May 3, 2020
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223Viviana Frantellizzi, Fabio Monari, Manlio Mascia, et al.Science Translational Medicine|October 15, 2011
Diabetes impairs hematopoietic stem cell mobilization by altering niche functionFrancesca Ferraro, Stefania Lymperi, Simón Méndez-Ferrer, et al.Biomedicines|May 16, 2023
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian StudyMaria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|March 10, 2010
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?Lucia Prezioso, Silvia Tanzi, Federica Galaverna, et al.Journal of Clinical Medicine|December 23, 2022
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added ValueCristina Mosconi, Alberta Cappelli, Cinzia Pettinato, et al.Pageof 5